Healthcare provider profile · identity verified

Stacy Lynn Halcomb-Brooks, NP

Nurse Practitioner · RICHMOND, IN · NPI 1497293377

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	426	86
Atorvastatin Calcium	Atorvastatin Calcium	413	94
Gabapentin	Gabapentin	366	65
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	315	52
Levothyroxine Sodium	Levothyroxine Sodium	243	51
Montelukast Sodium	Montelukast Sodium	209	42
Metformin Hcl	Metformin Hcl	196	42
Lisinopril	Lisinopril	184	44
Famotidine	Famotidine	172	40
Potassium Chloride	Potassium Chloride	160	28
Buspirone Hcl	Buspirone Hcl	158	35
Albuterol Sulfate Hfa	Albuterol Sulfate	156	54
Hydrochlorothiazide	Hydrochlorothiazide	152	37
Tramadol Hcl	Tramadol Hcl	148	35
Hydroxyzine Hcl	Hydroxyzine Hcl	147	33
Trazodone Hcl	Trazodone Hcl	143	39
Diclofenac Sodium	Diclofenac Sodium	137	39
Furosemide	Furosemide	133	32
Mounjaro	Tirzepatide	131	19
Fluticasone Propionate	Fluticasone Propionate	127	55
Clonazepam	Clonazepam	124	22
Ropinirole Hcl	Ropinirole Hcl	117	24
Amlodipine Besylate	Amlodipine Besylate	110	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	107	23
Tamsulosin Hcl	Tamsulosin Hcl	106	27
Pantoprazole Sodium	Pantoprazole Sodium	103	28
Metoprolol Tartrate	Metoprolol Tartrate	102	24
Rosuvastatin Calcium	Rosuvastatin Calcium	96	23
Losartan Potassium	Losartan Potassium	92	22
Aripiprazole	Aripiprazole	89	13
Duloxetine Hcl	Duloxetine Hcl	88	14
Jardiance	Empagliflozin	88	16
Alprazolam	Alprazolam	84	15
Ozempic	Semaglutide	77	22
Sertraline Hcl	Sertraline Hcl	75	22
Metoprolol Succinate	Metoprolol Succinate	73	16
Prednisone	Prednisone	65	34
Oxybutynin Chloride Er	Oxybutynin Chloride	63	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	61	49
Alendronate Sodium	Alendronate Sodium	59	12
Lorazepam	Lorazepam	58	suppressed
Ibuprofen	Ibuprofen	57	17
Quetiapine Fumarate	Quetiapine Fumarate	57	suppressed
Levofloxacin	Levofloxacin	56	47
Nystatin	Nystatin	56	32
Mirtazapine	Mirtazapine	55	16
Ondansetron Odt	Ondansetron	55	21
Fluoxetine Hcl	Fluoxetine Hcl	54	12
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	53	12
Memantine Hcl	Memantine Hcl	52	12
Dicyclomine Hcl	Dicyclomine Hcl	51	11
Venlafaxine Hcl Er	Venlafaxine Hcl	50	suppressed
Azithromycin	Azithromycin	49	45
Naproxen	Naproxen	48	13
Pregabalin	Pregabalin	48	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	47	suppressed
Simvastatin	Simvastatin	47	suppressed
Carvedilol	Carvedilol	45	11
Citalopram Hbr	Citalopram Hydrobromide	45	11
Pioglitazone Hcl	Pioglitazone Hcl	45	suppressed
Clopidogrel	Clopidogrel Bisulfate	44	suppressed
Methylprednisolone	Methylprednisolone	44	34
Baclofen	Baclofen	42	suppressed
Linzess	Linaclotide	42	14
Warfarin Sodium	Warfarin Sodium	41	suppressed
Ondansetron Hcl	Ondansetron Hcl	40	23
Tizanidine Hcl	Tizanidine Hcl	39	11
Trulicity	Dulaglutide	39	suppressed
Fluconazole	Fluconazole	38	31
Glimepiride	Glimepiride	38	suppressed
Vraylar	Cariprazine Hcl	37	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	suppressed
Vilazodone Hcl	Vilazodone Hcl	36	suppressed
Meloxicam	Meloxicam	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Celecoxib	Celecoxib	33	suppressed
Sucralfate	Sucralfate	33	suppressed
Cephalexin	Cephalexin	32	27
Glyburide	Glyburide	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	28
Eliquis	Apixaban	31	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Loperamide	Loperamide Hcl	31	15
Prazosin Hcl	Prazosin Hcl	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	24
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	28
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Primidone	Primidone	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Methocarbamol	Methocarbamol	28	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Vascepa	Icosapent Ethyl	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Allopurinol	Allopurinol	25	suppressed
Finasteride	Finasteride	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Glipizide	Glipizide	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	11
Meclizine Hcl	Meclizine Hcl	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Topiramate	Topiramate	22	suppressed
Cimetidine	Cimetidine	21	suppressed
Benztropine Mesylate	Benztropine Mesylate	20	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	11
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	14
Konvomep	Omeprazole/Sodium Bicarbonate	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Desipramine Hcl	Desipramine Hcl	15	suppressed
Insulin Aspart	Insulin Aspart	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Amoxicillin	Amoxicillin	13	12
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Atenolol	Atenolol	12	suppressed
Budesonide	Budesonide	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Austedo	Deutetrabenazine	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error